Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Leiomyoma × ferrous sulfate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Anemia 3 Waldenstrom Macroglobulinemia 1 Sezary Syndrome 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Postoperative Complications 1 Neoplasms, Plasma Cell 1 Mycosis Fungoides 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Prolymphocytic 1 Leukemia, Mast-Cell 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Large Granular Lymphocytic 1 Leukemia, Hairy Cell 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 Leiomyoma 1

Interventions

telapristone acetate 15 ulipristal acetate 14 Uterine Myomectomy 11 vilaprisan 10 Leuprolide 8 asoprisnil 7 Mifepristone 7 relugolix 6 estradiol, norethindrone drug combination 6 elagolix 6 Uterine Artery Embolization 6 Tranexamic Acid 6 ulipristal 5 Estradiol 5 Bupivacaine 5 epigallocatechin gallate 4 Sodium Chloride 4 Norethindrone Acetate 4 Letrozole 4 Hysterectomy 4 linzagolix 3 Vitamin B 6 3 Misoprostol 3 Gonadotropin-Releasing Hormone 3 Embolization, Therapeutic 3 cetrorelix 2 Vitamin D 2 Tea 2 Sugars 2 Saline Solution 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02825719 2020-04-09

Ulipristal Use in Chinese Population

Queen Mary Hospital, Hong Kong

Phase 4 Terminated

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡